Clinical influences of anticentromere antibody on primary Sjögren’s syndrome in a prospective Korean cohort

키워드

참고문헌 (34)

1. Fox RI, "Sjogren’s syndrome", Lancet, 366, pp.321~331 (2005)
2. Brito-Zeron P, "Sjogren syndrome", Nat Rev Dis Primers, 2, pp.16047~ (2016)
3. Shiboski CH, "2016 American College of Rheumatology", European League Against Rheumatism classification criteria for primary Sjogren’s syndrome : a consensus and data-driven methodology involving three international patient cohorts, 2017, pp.69, 35~45
4. Bournia VK, "Subgroups of Sjogren syndrome patients according to serological profiles", J Autoimmun, 39, pp.15~26 (2012)
5. Bournia VK, "Anticentromere antibody positive Sjogren’s syndrome : a retrospective descriptive analysis", Arthritis Res Ther, 12, pp.R47~ (2010)
6. Nakamura H, "Anti-centromere antibody-seropositive Sjogren’s syndrome differs from conventional subgroup in clinical and pathological study", BMC Musculoskelet Disord, 11, pp.140~ (2010)
7. Ramos-Casals M, "Atypical autoantibodies in patients with primary Sjogren syndrome : clinical characteristics and follow-up of 82 cases", Semin Arthritis Rheum, 35, pp.312~321 (2006)
8. Katano K, "Clinical and laboratory features of anticentromere antibody positive primary Sjogren’s syndrome", J Rheumatol, 28, pp.2238~2244 (2001)
9. Baer AN, "Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sjogren’s syndrome:analysis of the Sjogren’s International Collaborative Clinical Alliance Cohort", Arthritis Care Res (Hoboken), 68, pp.1554~1559 (2016)
10. Notarstefano C, "A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjogren’s syndrome", Clin Exp Rheumatol, 36(Suppl 112), pp.145~149 (2018)
11. Lee KE, "Anti-centromere antibody-positive Sjogren’s syndrome: a distinct clinical subgroup?", Int J Rheum Dis, 18, pp.776~782 (2015)
12. Vitali C, "Classification criteria for Sjogren’s syndrome : a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)
13. Shiboski SC, "American College of Rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the Sjogren’s International Collaborative Clinical Alliance cohort", Arthritis Care Res (Hoboken), 64, pp.475~487 (2012)
14. Thomson WM, "The Xerostomia Inventory : a multi-item approach to measuring dry mouth", Community Dent Health, 16, pp.12~17 (1999)
15. Whitcher JP, "A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry", Am J Ophthalmol, 149, pp.405~415 (2010)
16. van Bijsterveld OP, "Diagnostic tests in the Sicca syndrome", Arch Ophthalmol, 82, pp.10~14 (1969)
17. Schiffman RM, "Reliability and validity of the Ocular Surface Disease Index", Arch Ophthalmol, 118, pp.615~621 (2000)
18. Daniels TE, "Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren’s syndrome among 1, 726registry participants", Arthritis Rheum, 63, pp.2021~2030 (2011)
19. Seror R, "EULAR Sjogren’s syndrome disease activity index(ESSDAI) : a user guide", RMD Open, 1, pp.e000022~ (2015)
20. Vitali C, "Sjogren’s Syndrome Disease Damage Index and Disease Activity Index : scorlittleing systems for the assessment of disease damage and disease activity in Sjogren’s syndrome, derived from an analysis of a cohort of Italian patients", Arthritis Rheum, 56, pp.2223~2231 (2007)
21. Seror R, "EULAR Sjogren’s Syndrome Patient Reported Index(ESSPRI) : development of a consensus patient index for primary Sjogren’s syndrome", Ann Rheum Dis, 70, pp.968~972 (2011)
22. Lee YK, "South Korean time trade-off values for EQ-5D health states : modeling with observed values for 101 health states", Value Health, 12, pp.1187~1193 (2009)
23. Takeshita M, "Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12complex, in human salivary glands", Ann Rheum Dis, 79, pp.150~158 (2020)
24. Suzuki Y, "Impact of double positive for anti-centromere and anti-SS-a", Ro antibodies on clinicopathological characteristics of primary Sjogren’s syndrome : a retrospective cohort study, 2018, pp.28, 872~878
25. Park Y, "Distinct clinical characteristics of anti-Ro", SSA-negative primary Sjogren’s syndrome : data from a nationwide cohort for Sjogren’s syndrome in Korea, 2019, pp.37(Suppl 118), 107~113
26. Tsukamoto M, "Clinical and immunological features of anti-centromere antibody-positive primary Sjogren’s syndrome", Rheumatol Ther, 5, pp.499~505 (2018)
27. Yang WH, "Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?", Clin Gastroenterol Hepatol, 2, pp.1116~1122 (2004)
28. Tsianos EV, "Sjogren’s syndrome in patients with primary biliary cirrhosis", Hepatology, 11, pp.730~734 (1990)
29. Montano-Loza AJ, "Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren’s syndrome", Ann Hepatol, 6, pp.150~155 (2007)
30. Malladi AS, "Primary Sjogren’s syndrome as a systemic disease : a study of participants enrolled in an international Sjogren’s syndrome registry", Arthritis Care Res (Hoboken), 64, pp.911~918 (2012)
31. Caramaschi P, "Sjogren’s syndrome with anticentromere antibodies", Rev Rhum Engl Ed, 64, pp.785~788 (1997)
32. Peene I, "Diagnostic associations in a large and consecutively identified population positive for anti-SSA and", or anti-SSB : the range of associated diseases differs according to the detailed serotype, 2002, pp.61, 1090~1094
33. Gelber AC, "Distinct recognition of antibodies to centromere proteins in primary Sjogren’s syndrome compared with limited scleroderma", Ann Rheum Dis, 65, pp.1028~1032 (2006)
34. Tanaka N, "Anticentromere antibody-positive primary Sjogren’s syndrome : epitope analysis of a subset of anticentromere antibody-positive patients", Mod Rheumatol, 27, pp.115~121 (2017)

관련 논문AI추천